Palatin Technologies (PTN) Shares Issued (2012 - 2026)

Palatin Technologies' (PTN) quarterly Shares Issued came in at $78578.0 in Q1 2026, down 1.43% on a QoQ basis from $79720.0 in Q4 2025.

Palatin Technologies (PTN) Shares Issued (2012 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 14 years of Shares Issued data on file, last reported at $78578.0 in Q1 2026.

Quarterly Shares Issued changed N/A year-over-year to $78578.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78578.0 (changed N/A YoY) and the FY2025 annual result came in at $44805.0, changed N/A from the prior year.
Shares Issued eased to $78578.0 in Q1 2026, from $79720.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $14.2 million in Q1 2022 to a low of $44805.0 in Q2 2025.
A 4-year average of $2.1 million and a median of $430873.0 in 2023 frame the typical range for Shares Issued.
The widest YoY moves for Shares Issued: up 33.22% in 2023, down 96.96% in 2023.
Tracing PTN's Shares Issued over 4 years: stood at $420536.0 in 2022, then jumped by 268.72% to $1.6 million in 2023, then slumped by 94.86% to $79720.0 in 2025, then fell by 1.43% to $78578.0 in 2026.
The last three Shares Issued figures came in at $78578.0 (Q1 2026), $79720.0 (Q4 2025), and $44805.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Palatin Technologies	40.37 Mn	40.37 Mn	-	78,578.00

Download Data